Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.
RSS Headlines
Fool UK